Market Research Logo

Epigenomics AG (ECX) - Financial and Strategic SWOT Analysis Review

Epigenomics AG (ECX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi proLung, a validating test for the diagnosis of lung cancer. The company’s molecular diagnostic products are based on its proprietary methylation technology, which is based on biological phenomenon called DNA methylation. Epigenomics’ pipeline also comprises tests for monitoring, screening, diagnosis and prognosis assessment of colorectal and lung cancer. It also offers services such as basic research, product development, validate DNA methylation (epigenetic) biomarkers and support for obtaining regulatory approvals. Epigenomics is headquartered in Berlin, Germany.

Epigenomics AG Key Recent Developments

May 09,2018: Epigenomics announces 2018 First Quarter Financial Results
Mar 23,2018: Epigenomics Reports Results for Financial Year 2017
Nov 29,2017: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive VP Finance and a Member of the Management Board (Vorstand)
Nov 15,2017: Epigenomics Announces 2017 Third Quarter and Nine Months Financial Results
Nov 08,2017: Epigenomics Appointment of Director Reimbursement and Medical Affairs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Epigenomics AG - Key Facts
Epigenomics AG - Key Employees
Epigenomics AG - Key Employee Biographies
Epigenomics AG - Major Products and Services
Epigenomics AG - History
Epigenomics AG - Company Statement
Epigenomics AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Epigenomics AG - Business Description
Epigenomics AG - Corporate Strategy
Epigenomics AG - SWOT Analysis
SWOT Analysis - Overview
Epigenomics AG - Strengths
Epigenomics AG - Weaknesses
Epigenomics AG - Opportunities
Epigenomics AG - Threats
Epigenomics AG - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Epigenomics AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Epigenomics AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Epigenomics AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 09, 2018: Epigenomics announces 2018 First Quarter Financial Results
Mar 23, 2018: Epigenomics Reports Results for Financial Year 2017
Nov 29, 2017: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive VP Finance and a Member of the Management Board (Vorstand)
Nov 15, 2017: Epigenomics Announces 2017 Third Quarter and Nine Months Financial Results
Nov 08, 2017: Epigenomics Appointment of Director Reimbursement and Medical Affairs
Nov 05, 2017: Supervisory Board of Epigenomics Appoints Dr. Jorge Garces as President and Chief Scientific Officer
Aug 09, 2017: Epigenomics Announces 2017 Second Quarter and Six Months Financial Results
Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017
May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results
Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Epigenomics AG, Key Facts
Epigenomics AG, Key Employees
Epigenomics AG, Key Employee Biographies
Epigenomics AG, Major Products and Services
Epigenomics AG, History
Epigenomics AG, Subsidiaries
Epigenomics AG, Key Competitors
Epigenomics AG, Ratios based on current share price
Epigenomics AG, Annual Ratios
Epigenomics AG, Annual Ratios (Cont...1)
Epigenomics AG, Interim Ratios
Epigenomics AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Epigenomics AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Epigenomics AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Epigenomics AG, Performance Chart (2013 - 2017)
Epigenomics AG, Ratio Charts
Epigenomics AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Epigenomics AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report